Home
>
National Drug Code (NDC)
>
Podofilox
Podofilox - 0591-3204-13 - (Podofilox)
Drug Information of Podofilox
| Product NDC: | 0591-3204 |
| Proprietary Name: | Podofilox |
| Non Proprietary Name: | Podofilox |
| Active Ingredient(s): | 5 mg/mL & nbsp; Podofilox |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Podofilox
| Product NDC: | 0591-3204 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019795 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 19901213 |
Package Information of Podofilox
| Package NDC: | 0591-3204-13 |
| Package Description: | 3.5 mL in 1 BOTTLE, GLASS (0591-3204-13) |
NDC Information of Podofilox
| NDC Code | 0591-3204-13 |
| Proprietary Name | Podofilox |
| Package Description | 3.5 mL in 1 BOTTLE, GLASS (0591-3204-13) |
| Product NDC | 0591-3204 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Podofilox |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 19901213 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | PODOFILOX |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Mitosis [PE] |
